Canada approves Pfizer's oral COVID-19 antiviral pills.

M2 EQUITYBITES-January 18, 2022-Canada approves Pfizer's oral COVID-19 antiviral pills

(C)2022 M2 COMMUNICATIONS http://www.m2.com

Canada has approved Paxlovid, US pharmaceutical company Pfizer Inc's (NYSE:PFE) oral antiviral treatment, for mild to moderate cases of COVID-19 in adults, Reuters news agency reported on Tuesday.

Chief public health officer, Theresa Tam, was quoted as telling reporters on Monday: "(This approval) is particularly important, as access to easy to use treatments could help to reduce the severity of COVID-19 in adults who become newly infected."

The Canadian government has signed a deal with Pfizer for a million treatment courses, pending approval.

However, there is a global...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT